Stay updated with breaking news from Carl Feldbaum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After the CIA was compelled to release all the information it knew about the JFK assassination, a dogged journalist tracked the Agency’s lies about Lee Harvey Oswald — and its attempt to cover them up.
- Total Revenues of $469.8 million, Cabozantinib Franchise U.S. Net Product Revenues of $409.6 million - - GAAP Diluted EPS of $0.25, Non-GAAP Diluted EPS of $0.31 - - Conference Call and Webcast...
Urges Shareholders to Vote FOR All of Exelixis’ 11 Recommended Director Nominees on the GOLD Proxy Card ... | May 1, 2023
ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) (the “Company”) today announced that Carl Feldbaum, Esq. and Vincent Marchesi, M.D., Ph.D., two long-standing and valued members of the Board of Directors, will not stand for re-election at the Company’s 2023 Annual Meeting of Stockholders (the “Annual...